UBS AG - ZIOPHARM ONCOLOGY INC ownership

ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 78 filers reported holding ZIOPHARM ONCOLOGY INC in Q4 2013. The put-call ratio across all filers is 0.74 and the average weighting 0.2%.

Quarter-by-quarter ownership
UBS AG ownership history of ZIOPHARM ONCOLOGY INC
ValueSharesWeighting
Q3 2014$729,000
-48.6%
276,333
-21.5%
0.00%
-100.0%
Q2 2014$1,418,000
+3.6%
351,914
+17.7%
0.00%0.0%
Q1 2014$1,369,000
-31.1%
298,946
-34.6%
0.00%
-50.0%
Q4 2013$1,986,000
+58.1%
457,325
+43.5%
0.00%
+100.0%
Q3 2013$1,256,000
+778.3%
318,803
+370.5%
0.00%
Q2 2013$143,00067,7610.00%
Other shareholders
ZIOPHARM ONCOLOGY INC shareholders Q4 2013
NameSharesValueWeighting ↓
DISCOVERY CAPITAL MANAGEMENT, LLC / CT 15,461,829$2,037,8690.36%
MSD Partners, L.P. 15,151,516$1,996,9700.16%
MSD Partners, L.P. 7,575,758$998,4850.08%
MAGNOLIA CAPITAL ADVISORS LLC 865,938$65,5520.03%
Allred Capital Management, LLC 253,000$33,3450.02%
CHIRON CAPITAL MANAGEMENT, LLC 77,023$10,1520.01%
Boxer Capital, LLC 1,100,000$144,9800.01%
GSA CAPITAL PARTNERS LLP 569,566$750.01%
Sugarloaf Wealth Management, LLC 75,500$9,9510.00%
Owen LaRue, LLC 11,825$1,5590.00%
View complete list of ZIOPHARM ONCOLOGY INC shareholders